Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ana Pertejo"'
Autor:
Francesco Perone, Pilar Zamora Auñon, Laura Rodríguez, David Vinal, Juan Caro-Codon, Ana Pertejo, Virginia Martínez Marín, Enrique Espinosa, Teresa López-Fernández
Publikováno v:
Monaldi Archives for Chest Disease (2022)
Trastuzumab therapy has dramatically changed breast cancer prognosis. Consensus documents recommend a close monitoring during therapy, not always feasible, especially in metastatic breast cancer. The purpose of this study is to describe trastuzumab c
Externí odkaz:
https://doaj.org/article/54e4f67b8480419bb45a6a437a16204d
Autor:
Jesús Miranda-Poma, Lucía Trilla-Fuertes, Elena López-Camacho, Andrea Zapater-Moros, Rocío López-Vacas, María Isabel Lumbreras-Herrera, Ana Pertejo-Fernandez, Juan Ángel Fresno-Vara, Enrique Espinosa-Arranz, Angelo Gámez-Pozo, Álvaro Pinto-Marín
Publikováno v:
Clinical and Translational Oncology. 24:2055-2063
MicroRNAs (miRNAs) are small RNA sequences that act as post-transcriptional regulatory genes to control many cellular processes through pairing bases with a complementary messenger RNA (mRNA). A single miRNA molecule can regulate more than 200 differ
Autor:
Jesús Miranda-Poma, Lucía Trilla-Fuertes, Rocío López-Vacas, Elena López-Camacho, Eugenia García-Fernández, Ana Pertejo, María I. Lumbreras-Herrera, Andrea Zapater-Moros, Mariana Díaz-Almirón, Antje Dittmann, Juan Ángel Fresno Vara, Enrique Espinosa, Pilar González-Peramato, Álvaro Pinto-Marín, Angelo Gámez-Pozo
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 384
Purpose: To explore the tumor proteome of patients diagnosed with localized clear cell renal cancer (ccRCC) and treated with surgery. Material and methods: A total of 165 FFPE tumor samples from patients diagnosed with ccRCC were analyzed using DIA-p
Autor:
Sergio Martinez-Recio, Juan Pablo Perez-Wert, Sara Martinez-Fdez, Diego Jimenez-Bou, Iciar Ruiz-Gutierrez, Jesus Peña, Ana Pertejo, Enrique Espinosa, Alvaro Pinto
Publikováno v:
Clinical genitourinary cancer. 20(4)
Docetaxel 75 mg/mWe retrospectively included patients with mPC treated with docetaxel in our institution. We compared data from patients treated with 3-weekly, 75 mg/mWe included 200 patients, 86% of whom presented castration resistant mPC. A total o
Autor:
Alvaro Pinto, Lucía Trilla-Fuertes, Jesus Miranda Poma, Naveen Vasudev, Eugenia García-Fernández, Rocio Lopez Vacas, Natalia Miranda, Michelle Wilson, Elena López-Camacho, Ana Pertejo, Maria Isabel Lumbreras-Herrera, Joanne C Brown, Andrea Zapater-Moros, Guillermo De Velasco, Daniel E. Castellano, María Pilar González-Peramato, Enrique Espinosa, Rosamonde Banks, Juan Angel Fresno-Vara, Angelo Gámez-Pozo
Publikováno v:
Journal of Clinical Oncology. 40:e16519-e16519
e16519 Background: Prognosis of localized clear cell renal cell carcinoma (ccRCC) patients is estimated by nomograms based on clinico-pathological factors. However, clinical guidelines do not recommend their use. Recently, pembrolizumab has demonstra
Autor:
Ana María Jimenez-Gordo, Ana López-Alfonso, X. Mielgo, Luis Enrique Chiara, Miriam Dorta, José Luis López, Berta Hernandez, Ana Pertejo, Raquel Molina, Gonzalo Colmenarejo, Javier Baena-Espinar, Rosa Álvarez-Álvarez, Ana Collazo-Lorduy, Ana Manuela Martín, Carlos Aguado, Ana Ramírez de Molina, Ana Sanchez, María Sereno, Ana Lopez-Martin, Enrique Casado
Publikováno v:
Cancers, Vol 13, Iss 4205, p 4205 (2021)
Cancers
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Volume 13
Issue 16
Cancers
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Volume 13
Issue 16
Simple Summary Infections with COVID-19 in neutropenic cancer patients are related to poor outcomes. A G-CSF treatment used in neutropenic cancer with SARS-CoV-2 infections is related to a higher rate of respiratory failure according to progressive a
Autor:
Ana M. Jimenez Gordo, Gonzalo Colmenarejo, Javier Baena Espinar, Carlos Aguado, Xabier Mielgo, Ana Pertejo, Rosa Maria Alvarez Alvarez, Ana Sanchez, Jose Luis Lopez, Raquel Molina, Ana López-Alfonso, Berta Hernandez, Luis Enrique Chara Velarde, Ana Manuela Martin, Ana Lopez, Miriam Dorta, Ana Collazo Lorduy, Francisco Zambrana, Enrique Casado, Maria Sereno
Publikováno v:
Journal of Clinical Oncology. 39:12105-12105
12105 Background: Infection by SARS-CoV-2 can turn into an acute respiratory infection. Approximately 15% of patients will develop a distress syndrome responsible in most cases of mortality. A host hyperinflammatory response induced by a cytokine sto
Autor:
Daniel B. Costa, Biagio Ricciuti, Gonzalo Recondo, Deepa Rangachari, Mark M. Awad, Francisco M. Marty, Sarah P. Hammond, Ana Pertejo-Fernandez
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 145
Objectives The safety and efficacy of immunotherapy among patients with history of hepatitis B (HBV) or hepatitis C virus (HCV) infection and non-small cell lung cancer (NSCLC) remains unclear as this population has traditionally been excluded from c
Autor:
Alejandro, Martín Quirós, Alberto, Borobia Pérez, Ana, Pertejo Fernández, Patricia, Pérez Perilla, Angélica, Rivera Núñez, Ana María, Martínez Virto, Manuel, Quintana Díaz
Publikováno v:
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias. 27(6)
To assess mortality in patients with potentially severe injuries and explore the correlation between mortality and the score on the GAP scale (Glasgow Coma Scale, age, and systolic blood pressure).Retrospective observational study of all patients wit